Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Beigene Ltd Ads (NQ: BGNE )

311.06 USD +9.06 (+3.00%)
Official Closing Price Updated: 5:42 PM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 223,600
Open 302.00
Bid (Size) 310.99 (3)
Ask (Size) 343.17 (1)
Prev. Close 302.00
Today's Range 301.07 - 313.90
52wk Range 136.48 - 388.97
Shares Outstanding 1,190,821,941
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BeiGene Presents Interim Analysis Results of RATIONALE 303 Trial of Tislelizumab in Second- or Third-Line Non-Small Cell Lung Cancer at the AACR Annual Meeting 2021
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced results from a planned... 
From Business Wire News Releases
BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical data on its... 
From Business Wire News Releases

Performance

YTD
+19.18%
+19.18%
1 Month
-7.25%
-7.25%
3 Month
-12.87%
-12.87%
6 Month
+2.39%
+2.39%
1 Year
+93.59%
+93.59%

More News

Read More
BeiGene Launches BRUKINSA® (Zanubrutinib) in Canada for Patients with Waldenström’s Macroglobulinemia
From Business Wire News Releases
BeiGene Provides Update on Phase 2 Clinical Trial of Zanubrutinib in Patients with COVID-19-Related Pulmonary Distress
From Business Wire News Releases
BeiGene Announces First Commercial Manufacturing Approval for Its State-of-the-Art Biologics Facility in Guangzhou, China
From Business Wire News Releases
QQQJ's Underlying Holdings Imply 11% Gain Potential
Tags ETFs
From ETF Channel
BeiGene Announces New Chief Financial Officer, Julia Wang
From Business Wire News Releases
111, Inc. Enters into First-Ever Strategic Partnership with BeiGene
From PR Newswire
Best Stocks To Buy Today? 4 Biotech Stocks To Know
Tags Market News
From StockMarket.com
BeiGene's Zanubrutinib Fails To Meet Efficacy Endpoints In Mid-Stage COVID-19 Study
Tags Biotech FDA Briefs
From Benzinga
Week In Review: Sorrento Acquires ACEA In $488 Million Deal Between Two San Diego-China Oncology Biopharmas
Tags Market News Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.